Adamastor Bioservices

Startup

Adamastor Bioservices is an Italian innovative start-up from 2024, focused on advanced molecular binding assays and support for drug discovery efforts.  Adamastor Bioservices positions itself at the intersection of biophysical assay development and translational biotechnology, providing innovative analytical services to pharmaceutical and biotech clients. Adamastor Bioservices specialises in molecular binding assays with the main focus on innovative real-time kinetic measurements of interactions between drug candidates and their targets via surface plasmon resonance and real-time cell binding assays. This combination of methods provides a deep view of how potential therapeutics interact with their targets in a cellular context. Adamastor Bioservices provides physiologically relevant data to accelerate decision-making in the discovery of therapies for neurodegenerative, inflammatory, and infectious diseases.

In 2025, Adamastor added experienced biotechnology professionals to its advisory structure, including experts with deep backgrounds in protein biochemistry and pharmaceutical research, supporting its technical credibility and strategic development.